Your search returned 9 results.

Sort
Results
1.
2.
3.
4.
5.
6.
7.
8.
9.
Survival after neoadjuvant chemotherapy with or without bevacizumab or everolimus for HER2-negative primary breast cancer (GBG 44-GeparQuinto)†. [electronic resource] by
Producer: 20150707 In: Annals of oncology : official journal of the European Society for Medical Oncology vol. 25
Availability: No items available.